The investment round was oversubscribed and was led by DFJ ePlanet Ventures with participation from existing corporate investor ResMed. BiancaMed, whose target markets are the fast growing mobile and home-health sectors, was founded in 2003 and is based in NovaUCD, the Innovation and Technology Transfer Centre at UCD.
BiancaMed, whose vision is to provide easy-to-use mobile phone and home based wellness and health monitoring technologies and services for use in daily life, was co-founded by Dr Philip de Chazal, Dr Conor Hanley and Professor Conor Heneghan as a spin-off from UCD’s School of Electrical, Electronic and Mechanical Engineering.
Speaking about the investment, Dr Conor Hanley, CEO said, “BiancaMed is delighted to have secured this significant investment from such a prestigious global investor, with a proven track record in growing successful medical technology companies. BiancaMed is also delighted to welcome Dennis Atkinson and Donald Fitzmaurice to the Board.” He added, “The money raised will be used to accelerate our technology development and our entry into rapidly growing markets that are expected to be very large.”
Increasingly stressful lifestyles, a rise in chronic diseases and obesity and an aging population are directly contributing to skyrocketing health care costs. BiancaMed is providing mobile phone and home based solutions that empower individuals and patients to better manage their wellbeing and health. In short, BiancaMed aims to transform wellbeing and health by providing the ultimate convenience in personal health monitoring.
At the core of BiancaMed’s product platform is a very sensitive motion sensor that detects heart rate and respiration - without having to touch a person - completely wirelessly. The sensor, combined with the company's sophisticated health analysis software, provides solutions to monitor sleep, diet and exercise - the three elements of wellbeing. The company's product line, initially including baby, home health and exercise monitors, will ultimately be converged with the convenience and ease of a mobile phone.
Donald Fitzmaurice of DFJ ePlanet Ventures speaking about the investment said, “We are very excited about BiancaMed and are looking forward to working closely with the founders and management to grow a successful company. Furthermore, all the ingredients for success are present: a major opportunity in personalised healthcare, a visionary and experienced team and a proven ability to innovate clinically at the outset.”
Dr Pat Frain, Director, NovaUCD speaking about the investment said, “A major priority for UCD is the commercialisation of its research through a combination of licensing and the formation of spin-out companies. BiancaMed is an excellent example of a start-up company which was established to commercialise UCD intellectual property created by the founders of BiancaMed.” He added, “This investment demonstrates that university spin-outs, such as BiancaMed with strong intellectual property and cutting-edge technology continue to have the potential to attract significant investment to implement their business development plans.”
Miceal Whelan | alfa
Medical gamma-ray camera is now palm-sized
23.05.2017 | Waseda University
Computer accurately identifies and delineates breast cancers on digital tissue slides
11.05.2017 | Case Western Reserve University
Scientists have developed a new method of characterizing graphene’s properties without applying disruptive electrical contacts, allowing them to investigate both the resistance and quantum capacitance of graphene and other two-dimensional materials. Researchers from the Swiss Nanoscience Institute and the University of Basel’s Department of Physics reported their findings in the journal Physical Review Applied.
Graphene consists of a single layer of carbon atoms. It is transparent, harder than diamond and stronger than steel, yet flexible, and a significantly better...
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
30.05.2017 | Life Sciences
30.05.2017 | Life Sciences
30.05.2017 | Physics and Astronomy